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Introduction 
Superior mesenteric artery thrombosis occurring in a 
patient with the antiphospholipid syndrome (APS) 
has been reported only once previously, in a woman 
taking the oral contraceptive pill, and who had 
systemic lupus erythematosis. We describe a pre- 
viously asymptomatic male patient. 
Case Report 
A 17-year-old male smoker presented acutely with a 3 
week history of worsening suprapubic pain associated 
with dysuria, 10 kg weight loss and anorexia. He had 
undergone treatment for I week with antibiotics for a 
presumed urinary tract infection. He did not improve. 
His previous health had been good. 
On examination he had lost weight and was grossly 
dehydrated. He was apyrexial but had a pulse rate of 
100 beats/min. His blood pressure was 120/80 
mmHg. The abdomen was diffusely tender, especially 
suprapubically. Bowel sounds were scanty. On rectal 
examination there was a tender mass palpable within 
the rectovesical pouch. 
The results of investigations included: haemoglobin 
18.3 g/dl, white cell count 27 × 109/1 (88% neu- 
trophils), sodium 114 mmol/1, potassium 4.8 mmol/l. 
Urine examination revealed moderate proteinuria nd 
40 × 106 red cells/1. Chest and abdominal X-rays 
were unremarkable. 
He was resuscitated with intravenous fluids and 
antibiotics. Laparotomy revealed approximately 100 
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cm of infarcted small bowel extending from the mid- 
jejunum to the ileum. The main trunk of the superior 
mesenteric artery was non pulsatile. Though the 
proximal jejunum appeared well perfused, the distal 
ileum was dusky with absent pulsation within the 
mesentry. The overtly necrotic bowel was resected and 
both ends exteriorised. A central venous feeding line 
was inserted. He was started on subcutaneous low 
molecular weight heparin. 
Perioperative blood samples taken into citrate anti- 
coagulant indicated the presence of anti-cardiolipin 
antibodies (ACLA) (IgG type 42 U/ml; normal < 10 
U/ml) and the presence of a lupus anticoagulant (LA) 
(Diluted Russell Viper Venum Time 1.5 ratio, Kaolin 
Cephalin Time 1.4 ratio). Low protein S activity and 
free antigen levels were considered to be secondary to 
the acute illness. Antithrombin III, protein C activity 
and antigen, plasminogen and heparin cofactor II 
levels were normal. Repeat blood testing confirmed 
the presence of ACLA and LA. As expected protein S 
levels normalised. The ACLA has remained positive 
for the 3 months of follow-up. Assays for the anti- 
nuclear factor and rheumatoid factor were negative. 
Histology of the resected bowel showed no evidence 
of vasculitis. 
Postoperatively he was anticoagulated with hepa- 
rin. An echocardiograph revealed a normal myocar- 
dium. Prior to reanastomosis superior mesenteric 
artery (SMA) angiography was performed. This con- 
firmed occlusion of the main stem of the SMA 
approximately 6 cm from its origin (Fig. 1) and 
showed no evidence of any intrinsic abnormality 
within the abdominal aorta. 
The remaining bowel, now well vascularised, was 
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Fig. 1. Angiogram showing occlusion of superior mesenteric artery. Site marked with arrow. 
reanastomosed ( ay 27) and he was discharged home 
on warfarin after an uneventful recovery. 
Discussion 
This 17-year-old man developed an SMA thrombosis 
and on repeated testing was found to have both LA 
and IgG ACLAs. These findings are consistent with 
the APS. Venous and arterial thrombosis are the 
hallmarks of this syndrome though, for reasons 
unexplained, it is extremely rare for the SMA to be 
involved. Thrombosis in the APS is poorly under- 
stood. The balance of evidence favours interference 
with the formation of prostacyclin in the endothelial 
cells by the anti-cardiolipin antibodies or by asso- 
ciated endothelial antibodies. 2 This raises the possibil- 
ity that the rarity of thrombosis within the SMA could 
be due to relatively high prostacyclin production at 
this site. This would not protect against thrombosis 
due to antithrombin III deficiency. 
Previous studies would suggest management by 
lifelong warfarin therapy. 3"4 Other methods of treat- 
ment have, as yet, no proven benefit. As the APS 
increases in frequency with age, it is possible that this 
diagnosis is more common than previously thought 
(mesenteric schaemia in older patients being assumed 
to be due to occlusive arterial disease). Screening of 
patients with mesenteric schaemia for LA and ACLA 
may identify further cases. This emphasises the need 
for adequate thrombophilia screening in young 
patients presenting with arterial occlusion. 
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